GILD EQUITY Biological Products, (No Disgnostic Substances) 2027 Quantitative Forecast

Gilead Sciences Inc (GILD) Stock Price Prediction 2027

Multi-horizon algorithmic price targets, Wall Street consensus calibration, reverse-DCF growth expectations & options volatility valuation

$166.53
$-2.45 (-1.45%)
Market Close: Nov 19, 2026
1-Year Base Target
$173.74 +4.3%
Constant-P/E algorithmic trajectory
Wall St. Consensus
$175.92 Bull $217
Institutional analyst mean target
Risk-Adjusted Consensus Fair Value
$158.33 -4.9% Overvalued
Forward P/E 16.4x • PEG 2.27
AI Quant Stance
HOLD 47/100
RSI 56.1 • MACD Bearish • Downtrend

Executive Forecast Synopsis (2027)

Synthesized fundamental, multiple & technical thesis for GILD

AI Research Note

GILD Price Forecast 2027: Our AI models project that GILD stock will rise to approximately $173.74 by 2027. This represents a potential 4.3% growth from the current trading price of $166.53. The overall market sentiment for GILD is currently neutral, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading with its most recent quarterly earnings growing by -20.2%. GILD shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2027 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 56.1, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2027 predicted target.

Quant Signal & Technical Posture

Composite equity rating reconciled with 1-year target trajectory

Score: 47.2/100
Composite Equity Stance
HOLD (Quant Score 47/100) — HOLD
Active Technical & Price Action Triggers
  • Price consolidating in 2.36% range for 11 days
  • Recent pattern: Engulfing - Strong reversal pattern
  • Price near support at $166.89
MACD Regime: Bearish
Volume Tape: Neutral

GILD Trajectory & Forecast Curve

Projected price curve from spot ($166.53) across 30D–3Y horizons

Term Structure of Price Targets

Constant-multiple earnings trajectory model

30D – 3Y
Horizon Target Price Implied Return
30 Days Near-Term $167.11 +0.3%
90 Days 1 Quarter $168.33 +1.1%
6 Months Medium-Term $170.13 +2.2%
1 Year Base Model $173.74 +4.3%
2 Years EXTENDED $180.86 +8.6%
3 Years EXTENDED $188.28 +13.1%
Wall Street 12M Consensus Target: $175.92

1-Year Scenario Distribution (Bull / Base / Bear)

Probability-weighted regime outcomes around the 12-month forecast horizon

Regime Matrix
Bull Case 30% Prob
$217.18 +30.4%

Best case scenario if strong fundamentals and market conditions align

Base Case 50% Prob
$173.74 +4.3%

Expected scenario based on current growth trajectory

Bear Case 20% Prob
$121.62 -27.0%

Downside scenario if market headwinds or disappointing results

LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $167.58 · IV 33.3%

GILD Path Scenario ($177 Target): Simulated 5-Day Swing & LEAP Payoffs

Compare $16,758 for 100 GILD shares against risk-defined 5-day option spreads and long-dated LEAP structures.

5-DAY BULLISH SWING Liq A

Dec 18 $170 / $180 Bull Call Spread

Buy 1x $170C · Sell 1x $180C · 31d

Net Entry $334 Debit
T+5d @ +5% Move +$214 (+64%)
Max Risk / Buffer $334 Capped
5d Edge & Liquidity 1.0x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $155 / $145 Bull Put Spread

Sell 1x $155P · Buy 1x $145P · 31d

Net Entry $145 Credit
Max Credit / Yield +$145 (+17.0% RoM)
Max Risk / Buffer -8.4% Cushion ($855 Mgn)
5d Edge & Liquidity 80% PoP · Liq A
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq A

Dec 18 $155P / $170-$180C Seagull

Sell 1x $155P · Buy 1x $170/$180C · 31d

Net Entry $139 Debit
T+5d @ +5% Move +$356 (+14.7% RoM)
Max Risk / Buffer -7.5% Put Cushion ($2,428 Mgn)
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Reverse-DCF Implied Growth, Supply-Chain Moat & R&D Velocity

Proprietary deep-tech expectations gap, supply-chain bottleneck scoring & patent/filing velocity

Deep-Tech & Valuation Intelligence
Reverse-DCF: What's Priced In Priced For Perfection
Market-Implied 5Y CAGR: 33.3%
Analyst Consensus CAGR: 7.3%
Expectation Gap (Implied vs Est): +26.0 pp
Universe: SPDR S&P Biotech ETF (10%/yr hurdle rate)
R&D & Commercialization Velocity +3 R&D Citations (7d)
90D Commercialization Mentions: 179 disclosures
R&D Publications Tracked: 5 publications
Commercialization Themes:
Antibody-Drug Conjugates (179)

Fair Value & Core Fundamentals

PEG-adjusted intrinsic valuation & balance-sheet multiples

-4.9% Overvalued
Risk-Adjusted Consensus Fair Value: $158.33
Spot: $166.53

Valuation analysis indicates GILD trades at a premium relative to near-term consensus growth (-4.9%).

PEG Ratio
2.27
Growth Premium
Implied Fair P/E
15.6x
Model Growth 5.6%
Forward P/E
16.44x
P/S Ratio (TTM)
6.76x
Rev Growth (YoY)
6.8%
EPS Growth (YoY)
-20.2%
Market Cap
$209,592M
52-Week High
$176.58
52-Week Low
$116.88

Technicals & Institutional Money Flow

Momentum oscillators, volume accumulation & key price levels

Neutral
Volume Tape: Neutral

Volume-weighted price action shows near-term supply/distribution pressure; watch support levels for stabilization.

RSI (14-Day)
56.1
Neutral
MACD Signal
Bearish
Primary Trend
Downtrend
Chaikin Money Flow
0.022
Money Flow Index
37.0
200-Day SMA
$148.98

Options Volatility Valuation: 1-Year Target Strike Strategy

Comparing LEAP Call Implied Volatility & Breakeven against the 1-Year Model Target — Derivative Strategy Signal, NOT an Equity Stock Rating

Options Strategy Only Strategy Score: 4/100
OPTIONS STRATEGY: OVERWRITING / CREDIT SPREADS
SELL COVERED CALLS / COLLECT PREMIUM (Options Overpriced vs. Target)
This is an Options Volatility Valuation signal (comparing Call IV to 1Y target), NOT a sell rating on GILD shares.
Rich Call Premium (Write / Overwrite)
Premium Collected
$20.35/sh
Profit at 1Y Target
$18.23/sh
Option Writer ROI
+89.6%
Applicable Structures
Covered Call (safest) • Naked Call (risky) • Credit Spread (defined risk)
Why Options Are Flagged for Premium Selling: The $175 Call (Dec 2027) requires GILD to exceed $195.35 at expiration just to break even. Because the conservative constant-P/E 1Y model target is $177.12, buying out-of-the-money calls carries negative expected value (Buyers lose 89.6% even if target hits. Premium is overpriced for 5.9% move.), whereas shareholders overwriting covered calls capture rich implied volatility.
1Y Constant-PE Target
$177.12
+5.9% vs spot
Evaluated Call Strike
$175.00
Exp: Dec 17, 2027
Call Mark Premium
$20.35
12.2% of spot price
Call Buyer Breakeven
$195.35
Above 1Y base target
Delta / Implied Prob
52.9%
Option market odds
Contract Liquidity
157 OI
Vol: 13 • Nov 19

Unusual Options Flow Alert (Short-Term Derivative Tape)

Short-term institutional sweep & implied volatility anomaly monitor (distinct from long-term equity rating)

Strong Alert (Options Flow)
Flow Alert Score
100/100
Tape Classification
Strong Alert (Options Flow)
Unusual Volume Score
100.0
Implied Volatility Spike
+91.5%
Derivative Tape Readout: Short-Term Derivative Tape: Strong unusual activity detected. Review for potential entry. (Reflects options volume & IV anomalies, not a long-term stock rating.)

Frequently Asked Questions (GILD 2027 Outlook)

What is the GILD stock price prediction for 2027?

Based on our AI analysis, GILD is predicted to reach $173.74 by 2027, representing a potential 4.3% increase from the current price of $166.53.

Is GILD stock a good buy right now?

Our analysis rates GILD as a HOLD (AI Quant Score 47.2/100) based on current technical and fundamental indicators. With a projected 4.3% upside in our 1-year constant-P/E model, investors should consider their risk tolerance and investment horizon.

What is GILD 52-week high and low?

GILD has a 52-week high of $176.58 and a 52-week low of $116.88. The stock is currently trading 5.7% below its 52-week high.

What is the technical analysis for GILD?

GILD is currently in a downtrend trend. The RSI of 56.1 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.

Where will GILD stock be in 3 years?

Our long-term projection estimates GILD could reach $188.28 by 2029, representing a 13.1% gain from current levels. Long-term predictions carry more uncertainty.

Quantitative Research Disclaimer: Price predictions, reverse-DCF expectations, and options volatility strategies are generated algorithmically from historical financial data, analyst consensus estimates, and live options chains. They are provided strictly for informational and research purposes and do not constitute investment advice. Always conduct independent due diligence before executing equity or derivative transactions.